| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.6M | -67.3% |
| R&D Expense | $423.1M | +67.2% |
| SG&A Expense | $75.6M | +86.3% |
| Operating Income | -$487.2M | -88.6% |
| Pre-tax Income | -$439.9M | -76.6% |
| Income Tax | -$3.5M | -739.0% |
| Net Income | -$436.4M | -75.5% |
| EPS (Basic) | -$3.86 | -25.3% |
| EPS (Diluted) | -$3.86 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $696.1M | +331.3% |
| Short-term Investments | $1.16B | +139.2% |
| Current Assets | $1.88B | +184.7% |
| Total Assets | $2.06B | +153.9% |
| Current Liabilities | $143.9M | +132.1% |
| Total Liabilities | $235.5M | +85.8% |
| Stockholders' Equity | $1.83B | +166.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$350.6M | -56.2% |
| Capital Expenditures | $7.7M | -28.5% |
| Investing Cash Flow | -$342.6M | -1320.6% |
| Financing Cash Flow | $1.23B | +307.8% |
| Free Cash Flow | -$358.3M | -52.3% |
| -25.3% |